STREAM (Standardized Treatment Regimen of Anti-TB Drugs for Patients with MDR-TB) Stage 1 demonstrated non-inferior efficacy of a shortened regimen (the Short regimen) for rifampicin-resistant TB (RR-TB) compared to the contemporaneous WHO-recommended regimen. This regimen included moxifloxacin and clofazimine, known to cause QT prolongation, and severe prolongation was more common on the Short regimen. This study investigated risk factors for QT prolongation with the Short regimen.
Recent Abstracts
Tobacco Control Case Study – Philippines
Psychosocial determinants of adherence to public health and social measures (PHSMs) in 18…
Capabilities Statement
Measuring misclassification of Covid-19 as garbage codes: Results of investigating 1,365 deaths and…
A Comprehensive Approach to Improving Emergency Obstetric and Newborn Care in Kigoma, Tanzania
Improving Maternal and Reproductive Health in Kigoma, Tanzania: A 13-Year Initiative
Covitel – Inquérito Telefônico de Fatores de Risco para Doenças Crônicas não Transmissíveis…
Promoting Healthy Environments for Children By Using Indicators
Validation of physician certified verbal autopsy using conventional autopsy: a large study of…
Inspirer une mobilité urbaine qui sauve des vies en améliorant la qualité de…